{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-034210","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2025-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.419531+00:00","generated_at":"2026-05-23T16:07:43.532381+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"confidence":"high","headline":"KALA BIO enters retention agreements with three top executives; bonuses tied to CHASE trial data","bullets":["Retention bonuses: Bazemore $281,190, Reumuth $234,000, Brazzell $260,000.","Bonuses payable by April 18, 2025; clawback if executive resigns or is terminated for cause before earlier of Sept 30, 2025 or CHASE trial topline data announcement.","CHASE trial of KPI-012 topline data expected Q3 2025 per exhibit.","Coverage includes Interim CEO, CFO, and Head of R&D/CMO, focusing on retaining key personnel ahead of trial results."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-034210","json":"https://secwatch.observer/filing/0001104659-25-034210.json","markdown":"https://secwatch.observer/filing/0001104659-25-034210.md","text":"https://secwatch.observer/filing/0001104659-25-034210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925034210/0001104659-25-034210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925034210/tm2512021d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T16:07:43.532381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}